Commentary · 21 Feb 2026
Research articlePublished 2012
In vivo Quantification of Abasic Sites for Efficacious Evaluation of DNA Targeted Chemotherapies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
DNA damage and repair represent important biological processes that are targets of various chemotherapies against cancer. In many ways, chemotherapeutic agents can induce DNA damage in cancerous as well as normal cells. However, DNA damage induced by chemotherapeutic agents can be intrinsically repaired by normal physiologic responses, which hampers inhibition of tumor growth and cause drug-resistance. Base excision repair (BER) is one such physiologic process that is important in the cellular response to many chemotherapeutic agents, specifically those agents that target DNAs. Once the BER pathway is triggered, damaged DNA bases undergo a series of chemical modifications resulting in the formation of abasic or apurinic/apyrimidinic (AP) site, which serves as key intermediates in the excision of damaged DNA bases and restoration of regular bases. To monitor BER- conferred intrinsic drug-resistance to chemotherapeutic agents such as DNA-alternating temozolomide (TMZ), pemetrexed (Alimta ® ), and fludarabine, we have developed a F-18 labeled fluoroethoxyamine ([ 11 C]FEX) as an imaging agent for positron emission tomography (PET) imaging of DNA damage and repair in vivo . In this work, we report the synthesis, radiolabeling, and evaluation of [ 18 F]FEX in vivo in mice. We have shown that [ 18 F]FEX- PET can be used to monitor DNA damage and repair in tumor xenograft mouse models including an uracil DNA glycosylase (UDG)-knockout tumor mouse model of non-small cell lung cancer (NSCLC).
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Wenxia Zhu”
- BylineArticles whose byline prints “Chunying Wu”
- BylineArticles whose byline prints “Yuguo Li”
- BylineArticles whose byline prints “Eduardo Somoza”
- BylineArticles whose byline prints “Lili Liu”
- BylineArticles whose byline prints “Stanton Gerson”
- BylineArticles whose byline prints “Yanming Wang”
